Evaluation of the distribution of enrofloxacin by circulating leukocytes to sites of inflammation in dogs

American Journal of Veterinary Research

Volumn 70, Issue 1, 2009, Pages 16-22

  Boothe, D M ^a,b   Boeckh, A ^a,c   Boothe, H W ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

^c ZOETIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; CARRAGEENAN; ENROFLOXACIN;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DOG; DRUG DISTRIBUTION; DRUG EXPOSURE; DRUG HALF LIFE; DRUG RELEASE; DRUG TISSUE LEVEL; DRUG TRANSPORT; EXTRACELLULAR FLUID; FEMALE; IN VITRO STUDY; INFLAMMATION; ISOTOPE LABELING; LEUKOCYTE; MALE; MEAN RESIDENCE TIME; NONHUMAN; SCINTIGRAPHY; STUDENT T TEST; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CARBON RADIOISOTOPES; DOGS; FEMALE; FLUOROQUINOLONES; INFLAMMATION; LEUKOCYTES; MALE; RANDOM ALLOCATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 58549095296     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.70.1.16     Document Type: Article

References (15)

1. Clarke CR. Tissue-chamber modeling systems - applications in veterinary medicine. J Vet Pharmacol Ther 1989;12:349-368.
2. Wattrang E, Wallgren P, Fuxler L, et al. Tissue chambers - a useful model for in vivo studies of cytokine production in the pig. Vet Immunol Immunopathol 1997;56:133-150.
3. Movat HZ. The vascular phenomena of acute inflammation. In: Movat HZ, ed. The inflammatory reaction. New York: Elsevier Science, 1985;43-65.
4. Boeckh A, Boothe DM, Wilkie S, et al. Time course of enrofloxacin and its active metabolite in peripheral leukocytes of dogs. Vet Ther 2001;2:334-344.
5. Boothe HW, Jones SA, Wilkie WS, et al. Evaluation of the concentration of marbofloxacin in alveolar macrophages and pulmonary epithelial lining fluid after administration in dogs. Am J Vet Res 2005; 66:1770-1774.
6. Carlier MB, Scorneaux B, Zenebergh A, et al. Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages. J Antimicrob Chemother 1990;26(suppl B):27-39.
7. Garraffo R, Jambou D, Chichmanian RM, et al. In vitro and in vivo ciprofloxacin pharmacokinetics in human neutrophils. Antimicrob Agents Chemother 1991;35:2215-2218.
8. Hawkins EC, Boothe DM, Guinn A, et al. Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs. J Vet Pharmacol Ther 1998;21:18-23.
9. Pascual A, Garcia I, Perea EJ. Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1989;33:653-656.
10. Schoevers EJ, van Leengoed LA, Verheijden JH, et al. Effects of enrofloxacin on porcine phagocytic function. Antimicrob Agents Chemother 1999;43:2138-2143.
11. Tulkens PM. Intracellular distribution and activity of antibiotics. Eur J Clin Microbiol Infect Dis 1991;10:100-106.
12. Cao CX, Silverstein SC, Neu HC, et al. J774 macrophages secrete antibiotics via organic anion transporters. J Infect Dis 1992;165:322-328.
13. Hogg JC, McLean T, Martin BA, et al. Erythrocyte transit and neutrophil concentration in the dog lung. J Appl Physiol 1988;65:1217-1225.
14. Boothe DM, Boeckh A, Boothe HW, et al. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg. Vet Ther 2002;3:409-419.
15. Hooper DC. Mechanisms of fluoroquinolone resistance. Drug Resist Updat 1999;2:38-55.